Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for ABVC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 -0.4215M
December 31, 2025 -0.5282M
September 30, 2025 -3.357M
June 30, 2025 0.00
March 31, 2025 -0.4117M
December 31, 2024 -0.0379M
September 30, 2024 -0.9023M
June 30, 2024 0.00
March 31, 2024 -0.3941M
December 31, 2023 0.0227M
September 30, 2023 -3.479M
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.2535M
September 30, 2022 -0.2535M
June 30, 2022 -3.664M
March 31, 2022 0.00
September 30, 2021 -6.025M
June 30, 2021 0.0404M
March 31, 2021 -0.0404M
December 31, 2020 -5.462M
September 30, 2020 0.0373M
June 30, 2020 -1.923M
March 31, 2020 -0.2677M
Date Value
December 31, 2019 -0.553M
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 -0.5311M
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
December 31, 2016 0.00
September 30, 2016 -2.35M
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 -0.949M
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00
September 30, 2013 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. 0.643M
Perspective Therapeutics, Inc. -0.16M
MiMedx Group, Inc. 12.60M
Abbott Laboratories 1.042B
AngioDynamics, Inc. 0.011M